Patents by Inventor Andrei Igorevich Voznesensky

Andrei Igorevich Voznesensky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
    Publication number: 20220213181
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: Regis CEBE, Igor SPLAWSKI, John TRAUGER, Andrei Igorevich VOZNESENSKY
  • LPL-GPIHBP1 FUSION POLYPEPTIDES
    Publication number: 20220025344
    Abstract: This disclosure relates to fusion polypeptides comprising lipoprotein lipase (LPL) and glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding protein 1 (GPIHBP1). The disclosure also relates to uses of such fusion polypeptides in treating disease such as familial chylomicronemia syndrome (FCS).
    Type: Application
    Filed: November 25, 2019
    Publication date: January 27, 2022
    Inventors: Jiaping GAO, Amitabh NIMONKAR, John TRAUGER, Andrei Igorevich VOZNESENSKY, Stephen Craig WELDON
  • ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
    Publication number: 20200392215
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: January 23, 2020
    Publication date: December 17, 2020
    Inventors: John TRAUGER, Andrei Igorevich VOZNESENSKY
  • Angiopoietin-like 4 antibodies and methods of use
    Patent number: 10577411
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: March 3, 2020
    Assignee: NOVARTIS AG
    Inventors: John Trauger, Andrei Igorevich Voznesensky
  • Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
    Patent number: 9988443
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoetin-like protein 4 (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: June 5, 2018
    Assignee: NOVARTIS AG
    Inventors: John Trauger, Andrei Igorevich Voznesensky, Julia Neugebauer, Steffen Runz
  • ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
    Publication number: 20180044410
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: August 25, 2017
    Publication date: February 15, 2018
    Applicant: Novartis AG
    Inventors: John TRAUGER, Andrei Igorevich VOZNESENSKY
  • Angiopoietin-like 4 antibodies and methods of use
    Patent number: 9771417
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: September 26, 2017
    Assignee: NOVARTIS AG
    Inventors: John Trauger, Andrei Igorevich Voznesensky
  • ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
    Publication number: 20160145326
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: August 6, 2015
    Publication date: May 26, 2016
    Applicant: NOVARTIS AG
    Inventors: John Trauger, Andrei Igorevich Voznesensky
  • ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE
    Publication number: 20160108110
    Abstract: The present invention relates to monoclonal antibodies binding to human angiopoetin-like protein 4 (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: August 6, 2015
    Publication date: April 21, 2016
    Applicant: NOVARTIS AG
    Inventors: John Trauger, Andrei Igorevich Voznesensky, Julia Neugebauer, Steffen Runz